Table 1.
Demographic, clinical, and paraclinical characteristics of the study population. Values are expressed as mean (standard deviation) for continuous variables and frequency (percent) for categorical variables
| Variable | Value |
|---|---|
| Age | |
| <25 | 7 (6.73%) |
| 25-39 | 22 (21.15%) |
| 40-64 | 64 (61.54%) |
| ≤65 | 11 (10.58%) |
| Gender | |
| Female | 54 (51.92%) |
| Male | 50 (48.08%) |
| Nationality | |
| Non-Saudi | 61 (58.65%) |
| Saudi | 43 (41.35%) |
| Smoking | |
| No | 100 (96.15%) |
| Yes | 4 (3.85%) |
| Hypertension | |
| Stage 1 | 82 (78.85%) |
| Stage 2 | 19 (18.27%) |
| Stage 3 | 3 (2.88%) |
| Diabetes Mellitus | |
| No | 65 (62.50%) |
| Yes | 39 (37.50%) |
| Dyslipidemia | |
| No | 73 (70.19%) |
| Yes | 31 (29.81%) |
| LVH | |
| 1 | 41 (39.42%) |
| 2 | 58 (55.77%) |
| 3 | 5 (4.81%) |
| Wall Motion Abnormality | |
| 1 | 81 (77.88%) |
| 2 | 23 (22.12%) |
| BMI | 33.91 (7.35) |
| BUN | 4.98 (3.12) |
| Creatinine | 76.11 (50.89) |
| HbA1c | 6.2 (1.83) |
| FBS | 6.56 (2.97) |
| LDL | 2.86 (1.01) |
| HDL | 1.18 (0.20) |
| Cholesterol | 4.65 (0.93) |
| Triglyceride | 1.52 (0.81) |